Ivermectin is an FDA-approved antiparasitic agent commonly used to treat various parasitic infections.
Ivermectin is an FDA-approved antiparasitic agent commonly used to treat various parasitic infections. Recent research has highlighted its potential antiviral, anti-inflammatory, and anticancer properties. It acts on multiple cellular pathways, offering promise as part of integrative cancer care.
Ivermectin is being actively explored in cancer treatment due to its ability to target multiple cancer-related pathways. It can promote cancer cell death (apoptosis), inhibit new blood vessel formation (angiogenesis), and alter the tumor environment to make it less supportive of cancer growth. Importantly, ivermectin also shows potential in overcoming drug resistance — helping certain cancer cells become more sensitive to chemotherapy and reducing the likelihood of treatment failure. While more clinical research is ongoing, it is increasingly considered as part of integrative cancer strategies.
